4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-042378
Chief Financial Officer sold 6,255 shares at an average $4.49 ($28,086)
From the SEC's structured data for this filing
Trades in this filing
Koppikar Utpal · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-16 | Sale : show line 1 in the form | −5,172 | $4.49 | $23,222 | 192,417 | D |
| 2022-11-16 | Sale : show line 2 in the form | −1,083 | $4.49 | $4,864 | 191,334 | D |
| Open-market sales · 6,255 sh · avg $4.49 · $28,086 | ||||||
Loading xslF345X03/form4.xml…